1. Home
  2. SG vs FLGT Comparison

SG vs FLGT Comparison

Compare SG & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sweetgreen Inc.

SG

Sweetgreen Inc.

HOLD

Current Price

$5.29

Market Cap

820.3M

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$15.64

Market Cap

867.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SG
FLGT
Founded
2007
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
820.3M
867.4M
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
SG
FLGT
Price
$5.29
$15.64
Analyst Decision
Hold
Buy
Analyst Count
14
3
Target Price
$8.55
$28.33
AVG Volume (30 Days)
3.9M
760.3K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$679,474,000.00
$18,730,000.00
Revenue This Year
$8.30
$10.66
Revenue Next Year
$7.82
$12.17
P/E Ratio
N/A
N/A
Revenue Growth
0.39
N/A
52 Week Low
$5.00
$13.46
52 Week High
$27.15
$31.04

Technical Indicators

Market Signals
Indicator
SG
FLGT
Relative Strength Index (RSI) 42.47 34.09
Support Level $5.10 $13.46
Resistance Level $6.16 $22.48
Average True Range (ATR) 0.36 0.64
MACD 0.01 0.37
Stochastic Oscillator 16.19 91.86

Price Performance

Historical Comparison
SG
FLGT

About SG Sweetgreen Inc.

Sweetgreen Inc is a mission-driven, next-generation restaurant and lifestyle brand that serves healthy food at scale. Its bold vision is to be as ubiquitous as traditional fast food, but with the transparency and quality that consumers increasingly expect. It is creating plant-forward, seasonal, and earth-friendly meals from fresh ingredients and produce that prioritizes organic, regenerative, and local sourcing.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: